Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
While both drugs are effective, tirzepatide's dual-agonist mechanism, targeting both GIP and GLP-1 receptors, is widely believed to be the reason for its weight loss results in clinical studies
Although all three can be used for weight control, they are not the same
Once a second generic version of a medication enters the market, the price for both typically drops to 50 per cent
GLP-1 agents, while costly and not yet guideline-endorsed for prevention, offer broader metabolic benefits without inherent bleeding risk
US$ 29.45
US$ 22.46
US$ 23.56
US$ 28.92
US$ 25.18
US$ 24.50
US$ 23.97
US$ 22.16
US$ 21.23
